Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada
Clinical trial NCT04398147 · UNKNOWN
Trial details
- NCT number
- NCT04398147
- Sponsor
- CanSino Biologics Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-12-20
- Enrollment
- 696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.